\
&
Contact us
Published on | 4 years ago
ProgrammesLast updated 22.06.2022
With the main submission deadline of this year behind us, it's time to have a look at the remaining open call topics for 2022. Currently there are 46 call topics in Cluster4 open for submission.
The submision deadlines are in about 3 months (range between 6 and 16 November) and all are single-stage calls.
In this article we'll have a quick look at the opportunities.
In order to quickly grasp the domains, it's best to look at the call topic acronyms. We can differentiate the following groups:
These are typically aimed at (consortia of) a very small niche of organisations that are willing to assist the EC in a certain domain. The topics in question are:
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space AI Continent
The Digital Europe-funded project LLM-Bridge has issued a cascade funding call to fund a high-quality, EU-based incubator capable of supporting startups in the transforming of early-stage GenAI ideas into viable, scalable, and ethically compliant ventures. read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.